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Abstract
Background: State-of-the-art strain engineering techniques for the host Pichia pastoris (syn. Komagataella spp.) include
overexpression of homologous and heterologous genes, and deletion of host genes. For metabolic and cell engineering
purposes the simultaneous overexpression of more than one gene would often be required. Very recently, Golden Gate
based libraries were adapted to optimize single expression cassettes for recombinant proteins in P. pastoris. However, an
efficient toolbox allowing the overexpression of multiple genes at once was not available for P. pastoris.
Methods: With the GoldenPiCS system, we provide a flexible modular system for advanced strain engineering in P.
pastoris based on Golden Gate cloning. For this purpose, we established a wide variety of standardized genetic parts
(20 promoters of different strength, 10 transcription terminators, 4 genome integration loci, 4 resistance marker cassettes).
Results: All genetic parts were characterized based on their expression strength measured by eGFP as reporter in up to
four production-relevant conditions. The promoters, which are either constitutive or regulatable, cover a broad range of
expression strengths in their active conditions (2–192% of the glyceraldehyde-3-phosphate dehydrogenase promoter
PGAP), while all transcription terminators and genome integration loci led to equally high expression strength. These
modular genetic parts can be readily combined in versatile order, as exemplified for the simultaneous expression of Cas9
and one or more guide-RNA expression units. Importantly, for constructing multigene constructs (vectors with more than
two expression units) it is not only essential to balance the expression of the individual genes, but also to avoid repetitive
homologous sequences which were otherwise shown to trigger “loop-out” of vector DNA from the P. pastoris genome.
Conclusions: GoldenPiCS, a modular Golden Gate-derived P. pastoris cloning system, is very flexible and efficient and can
be used for strain engineering of P. pastoris to accomplish pathway expression, protein production or other applications
where the integration of various DNA products is required. It allows for the assembly of up to eight expression units on
one plasmid with the ability to use different characterized promoters and terminators for each expression unit.
GoldenPiCS vectors are available at Addgene.
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Background
The yeast Pichia pastoris (syn. Komagataella spp.) is
frequently applied for the production of heterologous
proteins, most of which are efficiently secreted [1]. It is
also favored for the production of membrane proteins
[2], pharmaceuticals and chemical compounds [3] and as
a model organism for biomedical research [4]. New
genetic tools for P. pastoris such as promoters, signal
peptides, selection markers, Flp-frt/Cre-lox recombin-
ation and CRISPR/Cas9 have been reviewed recently [3].
Compared to other yeast species, P. pastoris is distin-
guished by its methylotrophy, its Crabtree-negative me-
tabolism, its growth to very high cell densities, the low
number and concentration of secreted host cell proteins
[5] and the availability of many genetic tools and indus-
trially relevant strains (humanized N-glycosylation, pro-
tease deficiency) [6]. Genomic integration into specific
loci is usually applied by using 5′ and 3′ homologous re-
gions and is crucially depending on the avoidance of re-
petitive homologous regions and the use of well-purified
vector DNA [7].
For recombinant protein production in P. pastoris, dif-
ferent highly efficient promoter systems were established
(reviewed by Weinhandl et al. [8]) and applied to pro-
duce up to several grams per liter of secreted heterol-
ogous products, covering proteins intended for
biopharmaceutical purposes as well as industrial en-
zymes [9]. The methanol utilization (MUT) pathway of
P. pastoris is very efficient and the corresponding genes
are highly induced on methanol [10, 11]. MUT pro-
moters (e.g. PAOX1, PDAS1/2 and PFLD1) as well as strong
constitutive promoters from highly expressed genes
(such as PGAP, derived from the glyceraldehyde-3-
phosphate dehydrogenase gene TDH3 and the promoter
of translation elongation factor PTEF1) are frequently ap-
plied [12]. Nevertheless, there is still room to further im-
prove productivity and/or protein quality. Besides
increasing transcriptional strength by using strong pro-
moters and higher gene copy numbers of the expression
cassettes, also cell engineering to boost the host’s folding
and secretion capacity or to provide precursors and en-
ergy for these processes proved to be beneficial for en-
hancing product titers (reviewed by Puxbaum et al. [1]).
Sometimes such cell engineering approaches require the
simultaneous overexpression of more than one gene to
reach their full potential (e.g. Nocon et al. [13], Delic et
al. [14]). On the other hand, gene knock-outs might be
necessary to avoid detrimental processes such as trans-
port to the vacuole or proteolysis (e.g. Idiris et al. [15]).
Both of these genetic manipulations require extensive
cloning and transformation efforts, which makes them
rather time-consuming and tedious.
Today, advanced synthetic biology tools are applied in
all fields of microbiology. New cloning methods such as
Gateway®, Gibson Assembly and Golden Gate cloning,
together with genome editing techniques like CRISPR/
Cas9 and TALEN (transcription activator-like effector
nucleases), enable efficient and highly specific cell engin-
eering and thereby revolutionized the whole field [16].
Golden Gate cloning is based on type IIs restriction
enzymes (which are cutting outside of their recognition
sequence) and offers important benefits: it does not require
long flanking DNA, it uses efficient one-pot reactions, al-
lows scar-less cloning and is cost-saving compared to many
other advanced techniques [17]. In Golden Gate Assembly
(GGA), the two different type IIs restriction endonucleases
BsaI and BpiI are used which yield four base pair overhangs
outside of their recognition sequence. These overhangs can
be freely designed and are termed fusion sites (Fs). These
fusion sites enable base pair precise assembly of genetic
parts such as promoters, coding sequences (CDS) and tran-
scription terminators. By using simultaneous restriction
and ligation in efficient one-pot cloning reactions, rapid
assembly of multiple DNA fragments is achieved [17].
Recently, Obst et al. [18] and Schreiber et al. [19] re-
ported the use of Golden Gate cloning for the gener-
ation of libraries of expression cassettes in P. pastoris,
which were tested for the production of reporter pro-
teins by the assembly of standardized parts such as pro-
moters, ribosome binding sites, secretion signals and
terminators in a fast and efficient way. These studies
aimed to optimize a single transcription unit for the pro-
duction of one heterologous protein of interest (either a
fluorescent reporter or an antimicrobial peptide). Vogl
et al. [20] used Gibson assembly with a set of MUT-
related promoters and novel transcription terminators
for the overexpression of multiple genes in P. pastoris
and could show a strong effect of the inserted promoters
when overexpressing the carotenoid pathway (crtE, crtB,
crtI, and crtY). Our study extends the versatile Golden
Gate technique for all applications in P. pastoris where
the simultaneous integration of multiple DNA products
is required (e.g. cell engineering, pathway expression,
protein production, co-expression of cofactors) and aims
beyond the mere assembly of single expression cassettes
for the heterologous protein of interest.
For this purpose, we adapted the Golden Gate based
modular cloning (MoClo) introduced by Weber et al. [21],
to create the GoldenPiCS (Golden Gate derived P. pastoris
cloning system) vector toolkit. GoldenPiCS is part of a
universal system termed GoldenMOCS, standing for
Golden Gate-derived Multiple Organism Cloning System
[22]. The GoldenMOCS platform enables versatile inte-
gration of host specific parts such as promoters, termina-
tors, and resistance cassettes, origins of replication or
genome integration loci to adapt the plasmid to the needs
of the experiment and the host cell to be engineered. Here,
we present the GoldenMOCS- subsystem GoldenPiCS
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designed for use in P. pastoris and the characterization of
its individual genetic parts using eGFP (enhanced green
fluorescence protein) as a reporter. Vectors of these
systems were deposited at Addgene as GoldenPiCS
kit (#1000000133).
Results and discussion
GoldenPiCS, our Golden Gate-derived P. pastoris clon-
ing system, consists of three hierarchical backbone (BB)
levels for flexible generation of overexpression plasmids
containing multiple transcription units (up to eight per
plasmid), four different selection markers and five loci
either for targeted genome integration or episomal
plasmid maintenance (Fig. 1). We mainly designed the
system to enable advanced cell engineering or the ex-
pression of whole metabolic pathways. In the lowest
cloning level, individual parts such as promoters, coding
sequences (e.g. reporters or GOIs) and transcription
Fig. 1 Assembly strategy and hierarchical backbone levels of the cloning systems GoldenMOCS and GoldenPiCS. In the microorganism-independent
general platform GoldenMOCS, DNA products (synthetic DNA, PCR products or oligonucleotides) are integrated into BB1 by a BsaI Golden Gate Assembly
and fusion sites Fs1, Fs2, Fs3 and Fs4. Fusion sites are indicated as colored boxes with corresponding fusion site number or letter. Basic genetic elements
contained in backbone 1 (BB1) can be assembled in recipient BB2 by performing a BpiI GGA reaction. The transcription units in BB2 are further used for BsaI
assembly into multigene BB3 constructs. Single transcription units can be obtained by direct BpiI assembly into recipient BB3 with fusion sites Fs1-Fs4.
Fusion sites determine module and transcription unit positions in assembled constructs. Thereby, fusion sites Fs1 to Fs4 are used to construct single
expression cassettes in BB2 and are required between promoter (Fs1-Fs2), CDS (Fs2-Fs3) and terminator (Fs3-Fs4). Fusion sites FsA to FsI are designed to
construct BB3 plasmids and separate the different expression cassettes from each other. The FSs are almost randomly chosen sequences and only FS2 has
a special function, because it includes the start codon ATG. GoldenPiCS additionally includes module-containing BB1s specific for P. pastoris: 20 promoters,
1 reporter gene (eGFP) and 10 transcription terminators, and recipient BB3 vectors containing different integration loci for stable genome integration in
P. pastoris and suitable resistance cassettes (Additional file 2)
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terminators are incorporated into backbone 1 (BB1)
plasmids, which are subsequently assembled to one tran-
scription unit in BB2. This is followed by the assembly
of multiple expression units into one BB3, which is de-
signed for subsequent genome integration in P. pastoris
(four different selection markers and four loci for tar-
geted genome integration are available). Contrary to
other cloning techniques, Golden Gate Assembly avoids
the need for excessive sequencing, because BB2 and BB3
constructs are assembled by ligation instead of overlap-
extension PCR (only BB1 inserts require sequencing
after assembly). Correct ligation is assured by defined fu-
sion sites (see Fig. 1): Fusion sites Fs1 to Fs4 are linked
to individual parts by PCR and required for their assem-
bly into a transcription unit (BB2) e.g. promoters with
coding sequences (‘CATG’, fusion site Fs2). Fusion sites
FsA to FsI are used for the assembly of multiple expres-
sion units in BB3 e.g. for fusing the first transcription
unit to the second (‘CCGG’, fusion site FsB). The differ-
ent BB3 vectors with fusion sites FsA-FsC, FsA-FsD, to
FsA-FsI are designed for the assembly of two, three, …
up to eight transcription units in one single plasmid. In-
ternal BsaI and BpiI restriction sites must be removed in
all modules by introducing point mutations, with con-
sideration of the codon usage of P. pastoris.
Previously, strain engineering approaches with P. pas-
toris often relied on pGAPz, pPIC6 (Invitrogen) or
related expression vectors, which harbor only one tran-
scription unit (Fig. 2). Cloning of concatemers contain-
ing more than two transcription units proved to be
highly time consuming and also led to unpredictable in-
tegration events when using repetitive promoter and ter-
minator sequences [23, 24]. Therefore, conventional
overexpression of n genes requires n cycles of preparing
competent cells and transforming them, and the use of n
different selection markers. For overexpression of three
factors plus screenings using consecutive transforma-
tions, the procedure would take at least 31 days (four
days for transformation and re-streak, five days for
screening and two days to prepare competent cells; Fig. 2,
upper panel). Furthermore, selection markers can be re-
moved and recycled, with the cost of an additional cycle
of competent-making and transformation (Fig. 2, middle
panel). In addition to that, the use of different
integration loci must be included to prevent ‘loop-out’
incidents of integrated DNA. Alternatively, co-
transformation of multiple vectors can be considered,
but this requires the use of several independent selection
markers, otherwise in our experience transformation ef-
ficiency is low and it is very unpredictable if all vectors
get integrated into the genome [25]. Our backbone BB3
Golden Gate plasmids can carry multiple transcription
units and hence significantly simplify and shorten the
procedure to one single transformation step. Integration
Fig. 2 Comparison of conventional and Golden Gate based strain engineering strategies for P. pastoris. Overexpression of multiple genes (GOIs)
in P. pastoris using conventional cloning plasmids requires several rounds of competent making (2 days), transformation (4 days including second
streak-out) and clone screening (5 days) and takes at least 31 days for three genes with three selection markers. Alternatively, multiple vectors can
be co-transformed at once, but resulting transformation efficiencies are usually very low and clonal variation increases. Appropriate flanking sites
for the selection marker (loxP or FRT sites) enable marker recycling by recombinases (Cre or Flp, respectively), but require one more round of
competent making and transformation which takes at least eight additional days. Golden Gate plasmids carry several transcription units at once
and thereby enable transformation and screening in only nine days
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of multiple transcription units plus screening lasts only
nine days (Fig. 2, lower panel). The thereby generated
strains benefit from decreased generation numbers and
milder selection procedures.
Recombination events by repetitive sequences disturb
full vector integration in P. pastoris
Initially, we started with Golden Gate vectors carrying
up to four transcription units with the same promoter
and transcription terminator (PGAP and ScCYC1tt). High
clonal variation prompted us to analyze gene copy num-
bers (GCN) of integrated genes and we found that indi-
vidual transcription units were lost. Similar results have
been obtained with PGAP or PAOX1 based multicopy vec-
tors [24], thus showing that incomplete vector integration
is not due to the Golden Gate backbone. We positively
confirmed post-transformational integration stability for
three of the transformants in three consecutive shake
flask- batch cultivations without selection pressure (gene
copy numbers were stable for more than 15 generations;
Additional file 1: Table S1). Therefore, we conclude
that repetitive homologous sequences within the expres-
sion vector (PGAP and ScCYC1tt sequences) resulted
in recombination events (internal ‘loop out’) during
transformation.
The high occurrence of incomplete vector integration
prompted us to establish a collection of 20 different pro-
moters and 10 transcription terminators (Table 1), in order
to avoid repetitive sequences when creating constructs car-
rying multiple expression units. Promoters and terminators
were selected based on the transcriptional regulation and
expression strength of their natively controlled genes in
published microarray experiments [26]. All of them were
screened in several production-relevant conditions (Add-
itional file 1: Table S2). In addition to established promoters
[3, 12], we selected novel yet uncharacterized promoter se-
quences based on their expression behavior in transcripto-
mics data from P. pastoris cells cultivated on different
carbon sources [26]. By applying this collection we aimed
to gain the ability to fine-tune the expression of integrated
genes. Ideally, promoters for cell engineering purposes
should cover a wide range of expression strengths and
allow constitutive as well as tunable expression. Transcrip-
tion terminators were selected from constitutively highly
expressed genes [26], many of them being derived from
ribosomal protein genes. Also ribosomal genes were re-
ported to be regulated at the level of mRNA stability [27],
which is one of the main functions of the 3’UTR contained
in the transcription terminator fragments.
Validation of Kozak sequence mutations in the PGAP
sequence of P. pastoris
In the GoldenMOCS setup, fusion site Fs2 that links the
promoter to the GOI contains the start codon ATG and
part of the Kozak sequence, which is important for
translational initiation in eukaryotes. As this fusion site
is a fixed variable in the Golden Gate system, we evalu-
ated the effect of the ‘-1’ position of the PGAP promoter
(position in front of the start codon, Fig. 3d) on reporter
gene expression in P. pastoris. Due to the ‘CATG’ fusion
site, the native ‘A’ in position ‘-1’ of the PGAP promoter
(‘-8’ to ‘-1’: AAAACACA) is changed to ‘C’ (AAAA-
CACC). While PGAP variants with ‘A’, ‘T’ and ‘C’ at pos-
ition ‘-1’ performed similarly, the variant with ‘G’
resulted in a lower eGFP level (PGAP_GATG; about 40%
lower compared to the other variants). The Kozak
consensus sequence of P. pastoris was analyzed and
found to be similar to that of S. cerevisiae, which is
rich in ‘A’ and poor in ‘G’ bases (Fig. 4). Based on
these results, eight bases of the A-rich Kozak consen-
sus sequence were tested in an additional PGAP
variant (PGAP_A8ATG; position ‘-4’ and ‘-2’ replaced
by ‘A’: AAAAAAAA) and a slightly increased expres-
sion of eGFP was found (Fig. 3d). Nevertheless, we
chose the ‘CATG’ fusion site for our GoldenPiCS
system and kept the ‘GCTT’ fusion site for the
GOI-terminator assembly.
Analysis of GoldenPiCS promoter and terminator strength
and regulation using eGFP
All promoters and terminators were characterized for their
capacity for expression of the intracellular reporter eGFP in
appropriate conditions (Additional file 1: Table S2): glycerol
or glucose excess (“G” and “D”, respectively, maximum spe-
cific growth rate μMAX~0.22 h
−1) as present in batch culti-
vation, limiting glucose (“X”, 12 mm glucose feed beads,
specific growth rate μ~ 0.04 h−1) and methanol feed (“M”,
μMAX up to 0.1 h
−1), the latter two representing conditions
as encountered during fed batch cultivation. PGAP was used
as reference to evaluate the expression strength of the pro-
moters. PTEF2, PGPM1, PRPP1B, PPDC1, PPOR1, PADH2, PFBA1–1,
PRPL2A, PLAT1, PPFK300 and PMDH3 were confirmed to have a
constitutive regulation with a range of eGFP expression of
2–192% of PGAP in all tested conditions (Fig. 3a and b). Pro-
moters responsive to thiamine (PTHI11), glycerol (PGUT1)
and methanol (PAOX1, PDAS1, PDAS2, PFDH1, PSHB17 and
PALD4) were well repressed (0% of PGAP) and induced (to
18–160% of PGAP) in the repressed and induced conditions,
respectively (Table 1 and Fig. 3b). The selected transcrip-
tion terminator sequences did not have large effects on
eGFP expression levels (tested with PGAP, normalized to ter-
mination with ScCYC1tt, Table 1 and Fig. 3c). However,
eGFP levels were about 20% lower compared to the other
terminators when using ScCYC1tt (also reported recently
in [7]), chr4_0883tt and RPL2Att. Recently, a set of tran-
scriptional terminators derived from MUT- and other
metabolic genes of P. pastoris was tested in combination
with expression under control of PAOX1 and a broader
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range of expression levels from 60 to 100% relative to
the AOX1 terminator was observed [20]. Compared
to that, transcription terminators of GoldenPiCS,
which were mainly selected from ribosomal genes
(reported to be regulated at the level of mRNA sta-
bility [27]), appear to result in more uniform expression
levels.
Evaluation of genome integration efficiency of GoldenPiCS
multigene constructs
Vectors containing up to five transcription units with-
out repetitive homologous sequences, including
PGAP_eGFP_ScCYC1tt in different positions of the
vector as readout, resulted in complete vector integration
for more than 97% of all P. pastoris transformants,
Fig. 4 Kozak consensus sequences of P. pastoris and S. cerevisiae. The sequences were retrieved by the regulatory sequence analysis tool (RSAT)
and illustrated using weblogo
Fig. 3 Relative eGFP levels obtained with various elements of the GoldenPiCS toolbox. Expression strength of different promoters in comparison to PGAP tested
on different carbon sources (a, b), expression levels for PGAP-controlled expression in combination with different transcriptional terminators (c), and comparison
of PGAP variants with alternative ‘-1’ nucleotides (d). At least 10 P. pastoris clones were screened to test promoter and terminator function in up to four different
conditions: glycerol and glucose excess as present in batch cultivation (“G”, “D”), limiting glucose (“X”) and methanol feed (“M”), both representing fed batch.
PGAP to PSHB17 were tested in ‘G’, ‘D’, ‘X’ and ‘M’ (A). PTEF2 to PPFK300 were validated in ‘D’, while PGUT1, PTHI11 and MUT-related promoters were tested in putative
repressed and induced conditions (‘D’/‘G’, ‘D’+/−100 μM thiamine and ‘D’/M, respectively) (B). PGAP variants with alternative ‘-1’ bases were analyzed in glucose
excess (‘D’). Relative eGFP levels are related to PGAP- controlled expression (A, B), terminator ScCYC1tt (B), or presented as relative value (C)
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although we observed a slight efficiency decrease with in-
creasing distance from the selection marker (Fig. 5a). Rela-
tive eGFP levels were very similar for all tested constructs.
In contrast, just 56% eGFP positive clones were obtained
when a control vector containing twice the identical tran-
scription unit with PGAP_eGFP_ScCYC1tt in between was
used (only 9 out of 16 clones contained an integrated
copy). To further increase our repertoire for strain engin-
eering purposes, Golden Gate constructs containing a sin-
gle eGFP transcription unit (PGAP_eGFP_ScCYC1tt)
targeted to different integration loci (AOX1tt, RGI2, ENO1
or NTS) were analyzed. The eGFP levels were similar with
all tested constructs expressing from different genomic
loci in P. pastoris (Fig. 5b).
Example of multi-gene construct assembly with GoldenPiCS
Efficient genome editing by the CRISPR/Cas9 system
was shown in many organisms including P. pastoris [28].
However, efficiencies and applicability were not uni-
formly high when using different targets or approaches.
We applied GoldenPiCS to assemble different alterna-
tives of the two transcription units of humanized Cas9
(hcas9) and single guide RNA (sgRNA) on one single
episomal plasmid and test them for their efficiency to
perform InDel mutations in P. pastoris (Fig. 6). The
assembled BB3 plasmids were episomally maintained in
P. pastoris by using the S. cerevisiae CEN/ARS locus in-
stead of a genome integration locus [29]. Initially, we
tested sgRNA expression with the SNR52 promoter
(RNAPIII promoter capable to express non-coding
RNA) and the SUP4 terminator from S. cerevisiae [30],
and hcas9 controlled by PScTEF and ScCYC1tt, but we
could not obtain InDel mutations in P. pastoris. Next,
we tried the strong RNAPII promoter PGAP and flanking
self-splicing hammerhead (HH, 5′) and hepatitis delta
virus (HDV, 3′) ribozyme sequences for correct process-
ing of the sgRNA [31] and observed an efficiency of up
to 90% when targeting eGFP, similar as described by
Weninger et al. [28]. To reduce potential loop-out prob-
lems of the Cas9 transcription unit encountered during
expression in P. pastoris, we exchanged the ScCYC1tt
terminator of the sgRNA transcription unit for the P.
pastoris-derived transcription terminator RPS25Att to
avoid repetitive sequences. Regarding the expression
of hcas9, we obtained similarly high efficiencies with
different promoters, however, growth was weaker
with PScTEF1 while it was almost unaffected when
using PLAT1 or PPFK300. Targeting efficiency was
mostly dependent on the applied sgRNA sequence, as
we found large differences for several examples: At
least two different sgRNAs designed by CHOP CHOP
[32] were tested for each target. In all cases, they re-
sulted in different efficiencies for InDel formation,
e.g. two different sgRNAs each targeting AOX1 and
DAS2, which are non-essential on glucose, resulted
in largely different efficiencies of 38% vs. 100% and
0% vs. 100%, respectively. Therefore, we recommend
to test at least two different sgRNAs for each target
sequence.
With this example we demonstrate the suitability of
GoldenPiCS to assemble several expression cassettes
on one vector and to rapidly create new variants by
exchanging parts like promoters, terminators or ex-
pression sequences. The GoldenPiCS based vectors
for the described CRISP/Cas9 approach are available
as separate kit at Addgene (Gassler et al. 2018.) This
allowed rapid optimization of a CRISPR/Cas9-BB3
for efficient InDel mutations in P. pastoris within a
short time.
Fig. 5 Genome integration efficiency of Golden Gate vectors without
repetitive homologous sequences (a) and expression of eGFP obtained
after integration into different genomic loci (b). Genome integration
efficiency (fraction of positive clones) are shown for P. pastoris
transformed with different Golden Gate vectors containing PGAP-
eGFP_ScCYC1tt: control plasmid (single eGFP), eGFP in position 2 with a
repetitive transcription unit (TU1) in position 1 and 3 (‘loop-out’ control)
and 4 quadruple combinations with eGFP in position 1, 2, 3 and 5 next
to four other transcription units TU1–4) (a). Genome integration was
verified by analyzing eGFP expression of each 16 (controls) and 22
clones (quadruple combinations), respectively. TU1–4 were cloned with
the promoters and transcription terminators PPOR1/RPS3tt, PPDC1/IDP1tt,
PADH2/RPL2Att and PMDH3/TDH3tt, respectively. Coding sequences of
TU1–4 were derived from various non-essential intracellular-protein
coding genes of P. pastoris with a length of 500–2000 bp. The influence
of the genomic integration locus was analyzed using vectors containing
only one transcription unit (PGAP_eGFP_ScCYC1tt) (b). In both cases clones
were screened under glucose surplus
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Conclusions
Advanced synthetic biology tools revolutionized genetic
engineering and are applied for many different organ-
isms today. Strain engineering of P. pastoris has been
shown to improve bottlenecks of protein synthesis,
folding and secretion [1, 6]. Recently, we reported that
overexpression of different pentose phosphate pathway
genes had synergistic effects on production of human
superoxide dismutase in P. pastoris [13], as were
combinations of individual enzymes involved in redox
homeostasis and oxidative protein folding [14]. For such
complex cell engineering approaches more efficient
strategies are needed. Recently, the carotenoid pathway
was introduced into P. pastoris and fine-tuned by using
a set of MUT-related promoters and terminators con-
structed by Gibson assembly [20, 33]. At about the same
time, we established GoldenPiCS, a Golden Gate based
modular cloning system for genetic engineering of P.
pastoris. Both systems facilitate the assembly of multiple
transcription units with the possibility to fine-tune the
expression of each target individually. In our opinion,
Golden Gate cloning has crucial advantages such as its
low price, broad flexibility and high efficiency. These ad-
vantages have inspired several research groups to apply
Golden Gate cloning for their purposes. So far, Golden
Gate based screening in P. pastoris was dedicated to
design and optimize the expression of a single recombin-
ant gene for its production in P. pastoris by high
throughput testing of different promoters and secretion
signals [18, 19]. In contrast, our GoldenPiCS system is
aimed to facilitate cell engineering by allowing the
overexpression of multiple genes e.g. redox partners or
metabolic enzymes that act in a common pathway.
Therefore, our system allows for the assembly of up to
eight expression units on one plasmid with the ability to
use different characterized promoters and terminators
for each expression unit. The latter was proven to be es-
sential to obtain stable transformants. The toolbox de-
scribed by Obst et al. [18] is based on the yeast toolkit
(YTK) and is primarily designed to test gene expression
of a heterologous protein of interest with different regu-
latory elements (with a strong focus on the comparison
Fig. 6 Overview of CRISPR/Cas9-BB3 plasmids assembled using GoldenPiCS. Transcription units for sgRNA (fusion of crRNA and tracrRNA [42]) and
hcas9 (with SV40 nuclear localization sequence at its C-terminus) with various promoters and transcription terminators were assembled in BB3cK_AC
(CEN/ARS locus, KanMX selection marker, fusion sites FsA-FsC). The plasmids were successfully used to generate InDel mutations in different genomic
loci and eGFP in P. pastoris. The effects of the tested constructs are summarized in the table below the vector scheme. Modules which worked most
efficiently are indicated in bold in the vector scheme
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of different published signal peptides), but is rather lim-
ited to a subset of 4–6 strong promoters and just em-
ploys two transcription terminators, one thereof taken
from the original YTK. It also overlaps with the high
throughput screening platform described by Schreiber et
al. [19], where two promoters and three different secre-
tion signals were tested for the production of antimicro-
bial plasmids. The GoldenPiCS system is not primarily
aimed for the expression screening of the heterologous
protein itself (although it can be used for it), but dedi-
cated to combinatorial cell engineering strategies or the
expression of whole metabolic pathways. We have thus
added an example on the assembly of CRISPR/Cas9 vec-
tors with 2 expression cassettes, where the issue of sta-
bility with repeated sequences (and its solution with the
promoter library) is illustrated, as well as the advantage
of fast assembly of elements. Aside from the develop-
ment of the GoldenPiCS toolkit, we have invested effort
to assay promoter and terminator strength in different
conditions, to validate the effect of the ‘-1’ position in
front of the start codon and to present data for the
‘loop-out’ effect in P. pastoris transformants. Import-
antly, we found that repetitive sequences on the expres-
sion vector lead to unwanted recombination events and
therefore must be avoided.
Overall, we present the hierarchical multi-organism
modular cloning system (GoldenMOCS) and provide
several modules and plasmids for P. pastoris: GoldenPiCS
consists of 20 P. pastoris promoters, 10 terminators (all P.
pastoris-derived, except for the terminator ScCYC1tt), 4
integration loci (RGI2, ENO1, NTS and AOX1tt) and one
locus for episomal plasmid maintenance, as well as 4
resistance marker cassettes (hphMX, natMX, kanMX and
ZeoR; the latter with loxP sites). With the currently
available set of fusion sites, assembly of up to eight
expression units per plasmid is possible. All of these are
available through Addgene (please note that the ARS/CEN
locus for episomal plasmid maintenance is only part of the
CRISPR/Cas9 kit; Gassler et al. 2018) and allow high
throughput assembly of multigene constructs for cell and
metabolic engineering purposes.
Methods
Strains and growth conditions
Escherichia coli DH10B (Invitrogen) was used for plasmid
amplification. Promoter and terminator studies were done
in P. pastoris (Komagataella phaffii) CBS7435(MutS),
obtained from Helmut Schwab, Graz University of
Technology, Austria. P. pastoris clones were screened in
24- deep well plates (Whatman, UK) using appropriate
media (complex YP media or synthetic M2 screening
media) [4] and selection markers (Additional file 1: Table
S3). Plasmids were linearized within the genome integration
locus (not applied for the episomal CRISPR/Cas9-BB3’s)
and transformed into electro-competent P. pastoris
by electroporation (2 kV, 4 ms, GenePulser, BioRad)
according to [4].
Molecular biology
Primer design and in silico cloning was performed using
the CLC Main Workbench Version 7.7.3. GoldenPiCS
module sequences and backbones are listed in Add-
itional file 2. Custom DNA oligonucleotides and gBlocks
(from IDT, BE), restriction enzymes, T4 Ligase, Q5 poly-
merase (all from New England Biolabs, DE, or Fermen-
tas, DE) and DNA cleanup kits (from Qiagen, DE, and
Promega, DE) were used for routine cloning work.
GoldenMOCS and GoldenPiCS
Basic principle and background
Golden Gate cloning [17, 34, 35], a modular cloning sys-
tem, was set up for simultaneous overexpression of mul-
tiple genes independent of the microorganism and
further developed for application in P. pastoris (see Fig. 1
for a schematic overview). We termed the basic system
GoldenMOCS, (Golden Gate-derived Multiple Organism
Cloning System) and the subsystem specialized for appli-
cation in P. pastoris was named GoldenPiCS (includes
GoldenMOCS plus further developments). The system is
generally comprised of three backbone (BB) levels. BB1
constructs harbor the three basic modules (promoters,
coding sequences and terminators), BB2 constructs are
used to assemble transcription units (promoter + CDS +
terminator) and BB3 are used to further combine mul-
tiple transcription units (Fig. 1).
Golden Gate cloning employs type IIs restriction en-
zymes (BsaI and BpiI) which cut outside of their recog-
nition site and enables scarless cloning, assembly of
multiple DNA fragments and efficient one-pot cloning
reactions (simultaneous restriction and ligation; termed
Golden Gate assembly reaction). Therefore, internal BsaI
and BpiI restriction sites must be removed from all
modules by introducing point mutations, respecting the
codon usage of the host organism (P. pastoris codon
usage reported by De Schutter et al. [36]).
Fusion sites, modules and plasmids (summarized in Fig. 1
and Additional file 2)
Golden Gate cloning applies the two type IIs restriction
endonucleases BsaI and BpiI, which yield four base pair
overhangs outside of their recognition sequence. These
overhangs - termed fusion sites (Fs) - can be freely
designed and are used to systematically assemble
modules in the GoldenMOCS.
Modules of the GoldenPiCS include basic modules
(promoters, CDSs, terminators), resistance cassettes, inte-
gration sites, and linkers (containing restriction sites for
DNA integration and excision; BB2 linkers additionally
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contain a 5′ located strong artificial transcriptional ter-
minator (BBa_B1007, modified E. coli thr terminator) to
prevent transcriptional read-through from the resistance
gene). The following nomenclature is used for basic mod-
ules: PXXXn or pXXXn for promoters, YYYn for coding se-
quences and ZZZntt for terminators. Modules from other
organisms are indicated by the initials of the species name,
e.g. ‘Sc’ for S. cerevisiae.
Recipient BB1 and BB2 plasmids were adapted from
pIDT-SMART (IDT, BE) and pSTBlue-1 (VWR, DE),
respectively (with kanamycin/ampicillin resistance). All
recipient backbones are comprised of an origin of replica-
tion for E. coli, a resistance cassette (for E. coli or P. pas-
toris, a linker with BpiI and/or BsaI cloning sites, while
BB3 additionally contains a genomic locus for integration
or episomal plasmid maintenance for P. pastoris.
Golden Gate assembly – BB1
The three basic modules promoter, CDS and terminator
are assembled into BB1 using primers with BsaI sites
and two appropriate fusion sites: Fs1-Fs2 to integrate
into recipient BB1_12 (for promotor modules), Fs2-Fs3
to integrate into BB1_23 (for CDS modules) and Fs3-Fs4
to integrate into BB1_34 (for terminator modules).
Multiple fragments (e.g. to introduce mutations or to
create fusion genes) can be assembled in the BB1 assem-
bly reaction by appropriate fusion site design. All inserts
which were assembled into BB1 need to be checked by
sequencing.
Golden Gate assembly – BB2
Single transcription units (promoter, CDS, terminator)
are assembled into a recipient BB2 using the fusion sites
Fs1, Fs2, Fs3 and Fs4. Depending on the intended pos-
ition of the transcription unit in BB3, the appropriate
BB2 is used: BB2_AB with FsA-FsB for the first, BB2_BC
with FsB-FsC for the second position, etc.
Golden Gate assembly – BB3
Multiple transcription units are assembled into a recipi-
ent BB3 using fusion sites appropriate for the number of
transcription units (e.g. A-C for two transcription units).
For overexpression of a single transcription unit, direct
cloning from BB1 into a special BB3, equipped with a
BB2 linker with BpiI restriction sites and fusion sites
Fs1-Fs4 (e.g. BB3aN_14) can be done.
BB3 creation
De novo assembly of BB3 plasmids can be done using a
BpiI Golden Gate Assembly reaction with the following
modules: linker, resistance cassette, integration locus
and Ori modules - including appropriate flanking fusion
sites (Fs1–2, Fs2–3, Fs3–4 and Fs4–1, respectively). In
order to create recipient BB3 for direct cloning with
BB1, the linker with fusion sites FsA-FsB can be replaced
using a BsaI reaction with BB2_AB – thereby introdu-
cing the BB2 linker with BpiI restriction sites and fusion
sites Fs1-Fs4. Amplification and sequencing primers are
included in Additional file 2.
BB3 plasmids for CRISPR/Cas9-mediated genome
editing were assembled as usual recipient BB3, consist-
ing of resistance cassette, Ori, CEN/ARS locus and a
linker containing fusion sites FsA-FsC for integration of
two transcription units (Additional file 2 and Fig. 6).
Golden Gate assembly reaction
One μL BsaI or BpiI (10 U), 40 U T4 Ligase (0.1 μL),
2 μL CutSmart™ Buffer (10×, NEB), 2 μL ATP (10 mM,
NEB) and 40 nM dilutions of PCR fragments and/or
carrier and recipient backbone were diluted in 20 μL
total volume and incubated as follows: 8 to 50 cycles
(depending on insert number) of each 2 min at 37 °C
and 16 °C, followed by 10 min at 37 °C, 30 min at 55 °C
and 10 min at 80 °C (final ligation, digestion and heat
inactivation).
Characterization of genetic parts in P. pastoris
For evaluation of promoter and terminator function
(screening), P. pastoris transformants were cultivated at
25 °C on a rotary shaker at 280 rpm. Screening conditions
were designed to represent bioreactor cultivation phases
(Additional file 1: Table S2). Briefly, glycerol and glucose
excess conditions (“G”, “D”) as present in batch cultivation
were analyzed at a high growth rate of μMAX~0.22 and an
OD600 of about 3–8. Limiting glucose (“X”, 12 mm glu-
cose feed beads, releasing glucose at a non-linear rate of
1.63 ∙ t0.74 mg per disc, Kuhner, CH) and methanol feed
(“M”), representing fed batch conditions, were measured
at an OD600 of about 10 and growth rates around 0.04 h
−1
and μMAX-MeOH (up to 0.1 h
−1), respectively. Growth rates
and biomass increase can roughly be calculated from the
substrate yield coefficient, which is YX/S ~ 0.5 for μ >
0.05 h−1 on glucose [37] and YX/S ~ 0.6 on glycerol [38],
while it is lower on sole methanol (YX/S ~ 0.4) and metha-
nol culture lag phases are prolonged [39].
Flow cytometry
Analysis of eGFP levels in screenings and corresponding
calculations were done as described before [40, 41].
Briefly, fluorescence intensity is related to the cell volume
for all data points, resulting in specific eGFP fluorescence.
Thereof, the population’s geometric mean is normalized
by subtracting background signal (of non-producing P.
pastoris wild type cells) and related to expression under
the control of PGAP. Indel mutation screenings with
CRISPR/Cas9-BB3’s were done in a CBS7435(MutS) strain
stably expressing eGFP under control of the PGAP pro-
moter (integration in the native PGAP locus). Disruption
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frequency of eGFP (InDel mutations) was analysed by flow
cytometry and verified by sequencing of individual clones.
InDel mutations using CRISPR/Cas9
Targeting efficiency of the modular CRISPR/Cas9 system
on native sequences was evaluated by disruption of the
coding sequences of AOX1 and DAS1 at two different po-
sitions each. CRISPR/Cas9-BB3s plasmids harboring the
Cas9/sgRNA transcription units were transformed into
electro-competent P. pastoris by electroporation (2 kV,
4 ms, GenePulser, BioRad) according to [4] and selected
on G418 agar plates. After restreaking the clones two
times on selective agar plates the targeted loci were
checked for InDel mutations by colony PCR, followed by
Sanger sequencing. Sequences of gRNAs and verification
primers are listed in Additional file 1: Table S4.
Additional files
Additional file 1: File contains additional Tables S1-S3. Table S1. Gene
copy numbers of four GOIs in three engineered Pichia pastoris strains
after three consecutive batch cultivations. Table S2. P. pastoris deep-well
screening conditions. Table S3. Selection markers. Table S4. sgRNA
sequences for CRISPR/Cas9 and verification primers for InDel mutations.
(PDF 277 kb)
Additional file 2: GoldenPiCS modules and plasmids. Modules and
plasmids are listed with corresponding cloning- and fusion sites and full
sequences. DNA orientation is 5’to 3′. All plasmids are available at
Addgene. (XLSX 33 kb)
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